These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 34455662)

  • 21. A national survey of screening and management of hypogammaglobulinemia in Canadian transplantation centers.
    Bourassa-Blanchette S; Knoll G; Tay J; Bredeson C; Cameron DW; Cowan J
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28423227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
    Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.
    Lavallée C; Labbé AC; Talbot JD; Alonso CD; Marr KA; Cohen S; Laverdière M; Dufresne SF
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridioides difficile infection in the allogeneic hematopoietic cell transplant recipient.
    Lo Porto D; Mularoni A; Castagnola E; Saffioti C
    Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14159. PubMed ID: 37787395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of Bezlotoxumab for Prevention of Recurrent
    Johnson TM; Howard AH; Miller MA; Allen LL; Huang M; Molina KC; Bajrovic V
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab294. PubMed ID: 34262988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
    Ganetsky A; Han JH; Hughes ME; Babushok DV; Frey NV; Gill SI; Hexner EO; Loren AW; Luger SM; Mangan JK; Martin ME; Smith J; Freyer CW; Gilmar C; Schuster M; Stadtmauer EA; Porter DL
    Clin Infect Dis; 2019 May; 68(12):2003-2009. PubMed ID: 30256954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies.
    Paudel S; Zacharioudakis IM; Zervou FN; Ziakas PD; Mylonakis E
    PLoS One; 2015; 10(4):e0124483. PubMed ID: 25886133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral vancomycin for Clostridioides difficile prophylaxis in allogenic hematopoietic cell transplant.
    Altemeier OJ; Konrardy KT
    Transpl Infect Dis; 2022 Apr; 24(2):e13790. PubMed ID: 35014136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization.
    Amjad W; Schiano T; Segovia MC; Malik A; Weiner J; Horslen S; Jafri SM
    Transpl Infect Dis; 2023 Feb; 25(1):e13951. PubMed ID: 36621893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
    Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
    Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review.
    Ciricillo J; Haslam D; Blum S; Kim MO; Liu C; Paulsen G; Courter J; Danziger-Isakov L
    Transpl Infect Dis; 2016 Oct; 18(5):706-713. PubMed ID: 27492796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal Microbiota Transplant in Pediatric Solid Organ Transplant Recipients.
    Rodig NM; Weatherly M; Kaplan AL; Ballal SA; Elisofon SA; Daly KP; Kahn SA
    Transplantation; 2023 Sep; 107(9):2073-2077. PubMed ID: 37211643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic Cell and Solid Organ Transplantation in the Same Patient: Long-Term Experience at the University of Minnesota.
    El Jurdi N; DeFor T; Adamusiak AM; Brunstein CG; Pruett T; Weisdorf DJ
    Transplant Cell Ther; 2021 Jan; 27(1):87.e1-87.e6. PubMed ID: 32949755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus infection and rehospitalization rates after allogeneic hematopoietic stem cell and solid organ transplantation: a retrospective cohort study using German claims data.
    Teschner D; Knop J; Piehl C; Junker S; Witzke O
    Infection; 2022 Dec; 50(6):1543-1555. PubMed ID: 35633464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant-a CIBMTR study.
    Ramanathan M; Kim S; He N; Chen M; Hematti P; Abid MB; Rotz SJ; Williams KM; Lazarus HM; Wirk B; Yin DE; Kanakry CG; Perales MA; Chemaly RF; Dandoy CE; Riches M; Ustun C
    Bone Marrow Transplant; 2023 Apr; 58(4):360-366. PubMed ID: 36543999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the National Healthcare Safety Network standardized infection ratio risk adjustment for healthcare-facility-onset
    Polage CR; Quan KA; Madey K; Myers FE; Wightman DA; Krishna S; Grein JD; Gibbs L; Yokoe D; Mabalot SC; Chinn R; Hallmark A; Rubin Z; Fontenot M; Cohen S; Birnbaum D; Huang SS; Torriani FJ
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):404-410. PubMed ID: 32052726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of Clostridium difficile infection in pediatric solid organ transplant recipients.
    Pant C; Deshpande A; Desai M; Jani BS; Sferra TJ; Gilroy R; Olyaee M
    Transpl Infect Dis; 2016 Feb; 18(1):31-6. PubMed ID: 26538348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Algorithm Addressing the Problem of Overdiagnosis of Clostridioides difficile Infections in Hematopoietic Stem Cell Transplantation Recipients: Effects on C. difficile Infection Rates and Patient Outcomes.
    Ford CD; Hoda D; Lopansri BK; Parra M; Sharma P; Asch J
    Transplant Cell Ther; 2023 Jul; 29(7):471.e1-471.e7. PubMed ID: 37086852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).
    Kauffman CA; Freifeld AG; Andes DR; Baddley JW; Herwaldt L; Walker RC; Alexander BD; Anaissie EJ; Benedict K; Ito JI; Knapp KM; Lyon GM; Marr KA; Morrison VA; Park BJ; Patterson TF; Schuster MG; Chiller TM; Pappas PG
    Transpl Infect Dis; 2014 Apr; 16(2):213-24. PubMed ID: 24589027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
    Romero S; Montoro J; Guinot M; Almenar L; Andreu R; Balaguer A; Beneyto I; Espí J; Gómez-Codina J; Iacoboni G; Jarque I; López-Andújar R; Mayordomo-Aranda E; Montalar J; Pastor A; Pastor M; Piñana JL; Rojas-Ferrer N; Sánchez-Lázaro I; Sandoval J; Sanz G; Sanz MÁ; Solé A; Sanz J
    Leuk Lymphoma; 2019 Jan; 60(1):142-150. PubMed ID: 29966464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.